HomeInsightsBoard of Directors

Jenburkt Pharmaceuticals Ltd Board of Directors

Jenburkt Pharmaceuticals Ltd Board of Directors

stocks purchased

₹ 0.5 Cr

Volume Transacted

(Nov 8, 2024)

stocks purchased

3.6 K

Stocks Traded

(Nov 8, 2024)

Last Updated on: Nov 09, 2024

Board of Directors at Jenburkt Pharmaceuticals Ltd

Name
Designation
Ashish ShahCompany Sec. & Compli. Officer
Ashish BhutaChairman & Managing Director
Dilip BhutaWhole Time Director & CFO
Hina MehtaNon-Exec. & Independent Dir.
KRISHNAN SUBHARAMANIndependent Director

Key Highlights

  • Ashish R Shah continues to serve as the Company Sec. & Compli. Officer in 2024, maintaining the same position as in the previous year.
  • Ashish U Bhuta continues to serve as the Chairman & Managing Director in 2024, maintaining the same position as in the previous year.
  • Dilip H Bhuta joins the board as Whole Time Director & CFO, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
  • Hina Ravindra Mehta joins the board as Non-Exec. & Independent Dir., in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
  • Sumit Ajaybhai Thakkar joins the board as Independent Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Image

Jenburkt Pharmaceuticals Ltd

NSE: JENBURKTPHARMA

PRICE

-

stock direction

Last updated on:

Last Ten Days Market Price

Date
leftPrice (₹)right
08 Nov 20241252.95
07 Nov 20241305.05
06 Nov 20241232
05 Nov 20241087.15
04 Nov 20241013
01 Nov 2024987.15
31 Oct 2024960.4
30 Oct 2024959.2
29 Oct 2024983
28 Oct 20241013.55

Company Fundamentals for Jenburkt Pharmaceuticals Ltd

Market Cap

552 Cr

EPS

68.7

P/E Ratio (TTM) *

18.3

P/B Ratio (TTM) *

3.5

Day’s High *

1375.0

Day’s Low

1235.0

DTE *

0.0

ROE *

19.2

52 Week High

1375.0

52 Week Low

625.7

ROCE *

25.3

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Jenburkt Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Jenburkt Pharmaceuticals Ltd News Hub

News

Jenburkt Pharmaceuticals to announce Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5...

Read more

29 Oct 202415:24

News

Jenburkt Pharmaceuticals to declare Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2...

Read more

19 Jul 202410:24

News

Jenburkt Pharmaceuticals to conduct AGM

Jenburkt Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the compa...

Read more

24 Jun 202409:36

News

Board of Jenburkt Pharmaceuticals recommends final dividend

Jenburkt Pharmaceuticals announced that the Board of Directors of the Company at its meeti...

Read more

29 May 202410:57

News

Jenburkt Pharmaceuticals schedules board meeting

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2...

Read more

21 May 202415:36

News

Jenburkt Pharmaceuticals to announce Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6...

Read more

20 Jan 202412:45

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Board of Directors of Jenburkt Pharmaceuticals Ltd

How are members of Jenburkt Pharmaceuticals Ltd Board of Directors selected?

Members of the Jenburkt Pharmaceuticals Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Jenburkt Pharmaceuticals Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.

Can shareholders interact with the Jenburkt Pharmaceuticals Ltd Board of Directors?

Shareholders can interact with the Jenburkt Pharmaceuticals Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.

How often does the Jenburkt Pharmaceuticals Ltd Board of Directors meet?

The Jenburkt Pharmaceuticals Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.

What are the responsibilities of the Jenburkt Pharmaceuticals Ltd Board of Directors?

The Jenburkt Pharmaceuticals Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.

Who are the current members of the Board of Directors at Jenburkt Pharmaceuticals Ltd?

The current Board of Directors at Jenburkt Pharmaceuticals Ltd includes Ashish R Shah( Company Sec. & Compli. Officer) ,Ashish U Bhuta( Chairman & Managing Director) ,Dilip H Bhuta( Whole Time Director & CFO) ,Hina Ravindra Mehta( Non-Exec. & Independent Dir.) ,Sumit Ajaybhai Thakkar( Independent Director) . The full list can be found on Jenburkt Pharmaceuticals Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*